Redacted portions are indicated by [****]. DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENT Dated May 13, 2005 By and Between BioMarin Pharmaceutical Inc. And Ares Trading S.A.,Development, License and Commercialization Agreement • July 6th, 2005 • Biomarin Pharmaceutical Inc • Pharmaceutical preparations • New York
This DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENT (“Agreement”) is made effective as of the 13th day of May, 2005 (the “Effective Date”) by and between BioMarin Pharmaceutical Inc., a corporation organized under the laws of Delaware and having its principal place of business at 105 Digital Drive, Novato, California 94949 (“BioMarin”) and Ares Trading S.A., a corporation organized under the laws of Switzerland and having a principal place of business at Zone Industrielle de l’Ouriettaz, 1170 Aubonne, Switzerland (“Serono”). BioMarin and Serono are each referred to herein as a “Party” and collectively as the “Parties”.
